Inventiva (IVEVF) Common Equity (2018 - 2025)
Inventiva (IVEVF) posted Common Equity of -$33.2 billion for Q4 2025, down 329122.32% on a QoQ basis from -$10.1 million in Q2 2025, and down 29033.14% year-over-year from N/an in Q4 2024.
Analysis
Inventiva (IVEVF) Common Equity (2018 - 2025) Analysis & Trends
Inventiva has reported Common Equity for 8 years, with the latest figure at -$33.2 billion in Q4 2025.
- On a quarterly basis, Common Equity fell 29033.14% year-over-year to -$33.2 billion in Q4 2025; TTM through Dec 2025 was -$33.2 billion, a 29033.14% decrease from a year earlier, with the FY2025 full-year figure at -$33.2 billion, down 29033.14% from the prior year.
- Common Equity was -$33.2 billion for Q4 2025 at Inventiva, down from -$10.1 million in the prior quarter.
- The five-year high for Common Equity was $123.3 million in Q1 2021, with the low at -$33.2 billion in Q4 2025.
- Average Common Equity over 5 years is -$3.0 billion, with a median of -$8.3 million recorded in 2023.
- The sharpest annual moves came in 2021 and 2025: Common Equity jumped 131.92% in 2021, then plunged 29033.14% in 2025.
- Over 5 years, Common Equity stood at $101.7 million in 2021, then plunged by 54.36% to $46.4 million in 2022, then sank by 174.28% to -$34.5 million in 2023, then tumbled by 230.67% to -$114.0 million in 2024, then slumped by 29033.14% to -$33.2 billion in 2025.
- The last three Common Equity figures came in at -$33.2 billion (Q4 2025), -$10.1 million (Q2 2025), and -$114.0 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 106.07 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 85.49 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | 80.86 Bn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | 2.61 Bn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 6.34 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 6.40 Bn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | -33.20 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -33.20 Bn |
| Jun 30, 2025 | -10.08 Mn |
| Dec 31, 2024 | -113.96 Mn |
| Jun 30, 2024 | -85.14 Mn |
| Dec 31, 2023 | -34.46 Mn |
| Jun 30, 2023 | -8.35 Mn |
| Dec 31, 2022 | 46.40 Mn |
| Jun 30, 2022 | 74.40 Mn |
| Dec 31, 2021 | 101.66 Mn |
| Jun 30, 2021 | 106.60 Mn |
| Mar 31, 2021 | 123.34 Mn |
| Dec 31, 2020 | 132.60 Mn |
| Jun 30, 2020 | 45.97 Mn |
| Dec 31, 2019 | 45.82 Mn |
| Dec 31, 2018 | 70.31 Mn |